UROLOGY

SoftWave Therapy for Urologists

Utilizing broad-focused Li-ESWT technology, SoftWave Therapy revolutionizes urology with non-invasive treatments for men and women’s urological and sexual health issues.

  • Quick 10-minute sessions optimize clinic workflow without com promising treatment outcomes.
  • Broad treatment spectrum effectively managing a diverse range of urologic conditions.
  • Innovative urological care, merging superior effectiveness with simplicity, becoming a go-to option for urologists.
BECOME A PROVIDER

UROLOGY APPLICATIONS WITH SOFTWAVE THERAPY

Pelvic Chronic Pain Syndrome (PCPS) Pelvic Chronic Pain

Pelvic Chronic Pain Syndrome (PCPS) represents a significant clinical challenge, characterized by persistent pelvic pain in the absence of identifiable pathology. This condition, potentially stemming from musculoskeletal, neurologic, or psychosocial factors, impacts patient quality of life. SoftWave Therapy provides a non-invasive therapeutic option by:

  • Mitigating Inflammation: Directly reduces inflammation in the pelvic region, addressing a primary source of pain.
  • Facilitating Tissue Repair: Enhances the body’s inherent repair mechanisms, promoting recovery of the affected tissues.
  • Boosting Circulation: Improves blood flow to the pelvic area, essential for delivering nutrients and oxygen for tissue healing and pain mitigation.

Adopting SoftWave Therapy in pain management protocols offers a transformative, non-pharmacological approach that enhances patient well-being and functionality.

Erectile Dysfunction

Erectile Dysfunction (ED) is a multifactorial condition, affecting men’s health and well-being. With vascular, neurogenic, hormonal, and psychogenic factors at play, ED requires a multifaceted treatment approach. SoftWave Therapy emerges as an innovative aid, offering:

  • Enhanced Circulation: Improves blood flow to the penile tissue, critical for achieving and maintaining erections.
  • Vascular Restoration: Promotes the repair and rejuvenation of vascular pathways, improving erectile function.
  • Non-Invasive Management: A safe and discreet alternative to traditional ED interventions, favoring patient comfort and privacy.

Erectile Dysfunction

Erectile Dysfunction (ED) is a multifactorial condition, affecting men’s health and well-being. With vascular, neurogenic, hormonal, and psychogenic factors at play, ED requires a multifaceted treatment approach. SoftWave Therapy emerges as an innovative aid, offering:

  • Enhanced Circulation: Improves blood flow to the penile tissue, critical for achieving and maintaining erections.
  • Vascular Restoration: Promotes the repair and rejuvenation of vascular pathways, improving erectile function.
  • Non-Invasive Management: A safe and discreet alternative to traditional ED interventions, favoring patient comfort and privacy.

Peyronie Disease

Peyronie Disease, marked by fibrous scar tissue formation leading to penile curvature and pain, presents unique treatment challenges. Beyond the physical discomfort, it can significantly affect psychological well-being. SoftWave Therapy offers a novel therapeutic avenue by:

  • Scar Tissue Reduction: Aids in dissolving fibrous plaques, helping to decrease curvature and restore penile anatomy.
  • Pain Alleviation: Significantly reduces discomfort associated with Peyronie’s, enhancing sexual comfort.
  • Erectile Function Improvement: Boosts blood flow and tissue elasticity, contributing to enhanced erectile performance and sexual satisfaction.

PGAD and Other Women’s Sexual Health Issues

Persistent Genital Arousal Disorder (PGAD) and related sexual health concerns in women often lack adequate recognition and treatment. These conditions, resulting from an interplay of neurovascular and psychological factors, can lead to significant distress. SoftWave Therapy introduces a respectful and efficacious treatment modality by:

  • Symptom Relief: Minimizes discomfort and involuntary arousal, providing significant relief.
  • Tissue Health Promotion: Stimulates genital tissue recovery and functionality, addressing the root causes of sexual health challenges.
  • Sexual Wellness Enhancement: Supports overall sexual health improvement, fostering better quality of life and intimate relations.

PGAD and Other Women’s Sexual Health Issues

Persistent Genital Arousal Disorder (PGAD) and related sexual health concerns in women often lack adequate recognition and treatment. These conditions, resulting from an interplay of neurovascular and psychological factors, can lead to significant distress. SoftWave Therapy introduces a respectful and efficacious treatment modality by:

  • Symptom Relief: Minimizes discomfort and involuntary arousal, providing significant relief.
  • Tissue Health Promotion: Stimulates genital tissue recovery and functionality, addressing the root causes of sexual health challenges.
  • Sexual Wellness Enhancement: Supports overall sexual health improvement, fostering better quality of life and intimate relations.

Advantages of SoftWave Therapy for Healthcare Professionals

Elevate your practice to the forefront of medical innovation and achieve superior patient results with maximum ROI

  • Patented unfocused applicator
  • FDA-cleared
  • Easy to operate
  • Most effective
  • Quick recovery w/ no known side effects
  • Minimal contraindications
  • Increased revenue potential w/ superior ROI
LEARN MORE ABOUT SOFTWAVE TECHNOLOGY

SoftWave Is Trusted By Top Research And Medical Centers

Trusted by Nationally Respected Physicians and Organizations

"My staff and I feel the Softwave device is an invaluable tool in both identifying and treating orthopedic injuries. We utilize the device with upper extremity, lower extremity, and spine cases. Our players experience sustained reduction in inflammation and walle also experiencing near immediate restoration and range of motion."

Lonnie Soloff, PT, DPT, ATC - Senior Director, Medical Services Cleveland nolans Baseballi

"ESWT, using the OrthoGold machine is one of our most commonly employed biological treatment modalities that we use and is well-tolerated by the patients and has produced markedly improved clinical outcomes compared to other modalities."

Dr. Martin O Malley, Associate Professor of Orthopedic surgery at Weill Cornell Medical College. Team Orthopedist for the Brooklyn Nets, USA Basketball and lona College Athletics as well as the foot and ankle consultant for the New York Giants and New York City Ballet. His practice has a special emphasis on reconstructive surgery of the foot and ankle, and he has special expertise in ankle replacement and sports injuries of the foot and ankle.

Opportunities for Government Partnerships: GSA Contract Holder

SoftWave Therapy is not only a preferred choice among private healthcare providers but also a recognized option for government medical facilities, having secured a General Services Administration (GSA) contract

  • Effective from July 15, 2023, to July 14, 2028
  • Contract 36F79723D01671
  • Falls under Schedule 65 II A, dedicated to Medical Equipment and Supplies as part of Federal Supply
  • Schedule Solicitation RFP-797-FSS-99-0025-R10
LEARN MORE ABOUT SOFTWAVE TECHNOLOGY

SoftWave Therapy Indications

SoftWave’s patented broad-focused shockwave therapy devices are FDA-cleared and effective at treating a variety of soft tissue injuries and conditions.

Musculoskeletal Indications

Wound Healing

Women’s Pelvic Health & Sexual Health

Men’s Urological & Sexual Health

Musculoskeletal Indications

Wound Healing

Women’s Pelvic Health & Sexual Health

Men’s Urological & Sexual Health

Evidence Based Medicine is available for Low intensity shockwave therapy (Li-ESWT)

Low-Intensity Shockwave Therapy (Li-ESWT) is an evidence-based approach to improving patient outcomes.

FDA 510(k) cleared for

  • Activation of connective tissue
  • Treatment of chronic diabetic foot ulcers
  • Treatment of acute second-degree burns
  • ​Improved blood supply

Extracorporeal Shockwave Therapy in the Management of Sports Medicine Injuries

Alison N. Schroeder, MD; Adam S. Tonforde, MD

Efficacy of Unfocused Medium-Intensity Extracorporeal Shockwave Therapy (MI-ESWT) for Plantar Fasciitis

Alison N. Schroeder, MD; Adam S. Tonforde, MD

Extracorporeal Shockwave Therapy for Treating Chronic Low Back Pain: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Alison N. Schroeder, MD; Adam S. Tonforde, MD

Extracorporeal Shockwave Therapy for the treatment of chronic pelvic pain syndrome

Alison N. Schroeder, MD; Adam S. Tonforde, MD

Extracorporeal Shockwave Therapy in the Management of Sports Medicine Injuries

Alison N. Schroeder, MD; Adam S. Tonforde, MD

Efficacy of Unfocused Medium-Intensity Extracorporeal Shockwave Therapy (MI-ESWT) for Plantar Fasciitis

Alison N. Schroeder, MD; Adam S. Tonforde, MD

Extracorporeal Shockwave Therapy for Treating Chronic Low Back Pain: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Alison N. Schroeder, MD; Adam S. Tonforde, MD

Extracorporeal Shockwave Therapy for the treatment of chronic pelvic pain syndrome

Alison N. Schroeder, MD; Adam S. Tonforde, MD

Looking to
Purchase a
Shockwave
Therapy Machine?

Submit a Request

Fill out our Become a Provider Form to get started with a SoftWave representative

Explore Purchase Options

SoftWave is a GSA contract holder

Begin Treating Patients

SoftWave is easy to operate, does not require a physician, and suitable for use in non-clinical settings

Looking to Purchase a SoftWave Therapy Device?

BECOME A PROVIDER

Looking to try SoftWave Therapy?

FIND A PROVIDER